BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28652819)

  • 1. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis.
    Fuldeore MJ; Soliman AM
    Int J Womens Health; 2017; 9():403-411. PubMed ID: 28652819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
    Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
    Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
    BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
    Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
    J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
    Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
    Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an electronic daily uterine fibroid symptom diary.
    Deal LS; Williams VS; Fehnel SE
    Patient; 2011; 4(1):31-44. PubMed ID: 21766892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
    Koga K; Fukui M; Fujisawa M; Suzukamo Y
    J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the routine use of pelvic MRI in women presenting with symptomatic uterine fibroids: When is pelvic MRI useful?
    Vu KN; Fast AM; Shaffer RK; Rosenberg J; Dababou S; Marrocchio C; Vasanawala SS; Lum DA; Chen B; Hovsepian DM; Ghanouni P
    J Magn Reson Imaging; 2019 Jun; 49(7):e271-e281. PubMed ID: 30614145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine fibroids: Correlations of anemia and pain to fibroid location and uterine weight.
    Bachmann GA; Bahouth LA; Amalraj P; Mhamunkar V; Hoes K; Ananth CV
    J Reprod Med; 2011; 56(11-12):463-6. PubMed ID: 22195327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey.
    Soliman AM; Margolis MK; Castelli-Haley J; Fuldeore MJ; Owens CD; Coyne KS
    Curr Med Res Opin; 2017 Nov; 33(11):1971-1978. PubMed ID: 28836862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women.
    Fuldeore MJ; Soliman AM
    Gynecol Obstet Invest; 2017; 82(5):453-461. PubMed ID: 27820938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of symptomatic uterine fibroids in Canadian women: a cohort study.
    Laberge PY; Vilos GA; Vilos AG; Janiszewski PM
    Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States.
    Moshesh M; Olshan AF; Saldana T; Baird D
    J Sex Med; 2014 Mar; 11(3):800-8. PubMed ID: 24467730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids.
    Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
    Hervé F; Katty A; Isabelle Q; Céline S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plain language summary of the perspectives of women who were interviewed about their experiences with uterine fibroids.
    Hunsche E; Rakov V; Scippa K; Witherspoon B; McKain L
    J Comp Eff Res; 2024 May; ():CER. PubMed ID: 38804813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
    Woodhead N; Pounds R; Irani S; Pradhan P
    J Obstet Gynaecol; 2018 Aug; 38(6):813-817. PubMed ID: 29526144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.